GEN-MKT-18-7897-A
May 11, 2016 | Biopharma, Blogs | 0 comments
Fast LC-MS acquisition and automated data processing will help you speed up peptide mapping of your biotherapeutic, including critical disulfide bond and post-translational modification characterization. SCIEX helps you untangle the complexity of disulfide bonds, speeding up your characterization process.
See the full article by downloading the compendium >
Accurate disulfide bond mapping is essential for correctly establishing structure-function relationships as well as for monitoring the structural integrity of recombinant monoclonal antibodies (mAbs) throughout their production. Inappropriate disulfide bonds can affect a mAb’s stability, potency, aggregation, and may also signal errors in the cell culture or purification process. By following a biotherapeutic’s disulfide patterns over time, manufacturers can quickly detect production problems and then correct them as early as possible.
Correctly assigning disulfide bonds in a mAb, or ADC can be challenging and time-consuming due to the heterogeneity, large size, and multiple cysteine residues found in these biomolecules. Traditional approaches for disulfide mapping are based on fast liquid chromatography-mass spectrometry (LC-MS) analysis; however, these methods can be inefficient and usually involve digestion with multiple enzymes, tedious data processing, and intensive manual inspection of chromatograms for the identification of any possible disulfide linkages.
As the biotherapeutics industry develops and expands, there is an urgent need for software tools that can rapidly facilitate and accelerate the higher-order structural characterization of biopharmaceutical products. To meet these requirements, SCIEX has developed BioPharmaView™ Software, a data processing suite that can reduce the complexity of the massive data sets generated during biotherapeutic analysis. BioPharmaView Software uses rapid processing tools to accelerate critical characterization assays–such as peptide mapping and disulfide bond identification– by automating peak assignments, simplifying data processing, and streamlining the reporting process.
Peak Assignment Reduces Time for Peptide Mapping ExperimentsTo identify and match peptides, BioPharmaView Software automatically scores b- and y- ions from the high-resolution MS/MS spectra; and then the highest scoring experimental peaks are compared to a list of theoretical masses automatically generated by the software. The peak assignment process is further enhanced by predicting the theoretical fragment ion masses for non-reduced, disulfide-linked peptides before comparison with experimental data. Including other criteria in the ion selection process–such as MS/MS scoring, multiple charge states, and a retention time (RT) filter–can also help reduce the time needed for peptide mapping experiments. This enables manufacturers to meet regulatory requirements more quickly during the production and marketing of a new biotherapeutic product.
The ResultsIn this article, we successfully developed an efficient and automated workflow that comprehensively identified every disulfide linkage in the Fab region of an mAb. The use of the high-speed, TripleTOF® LC-MS System contributed to time-savings during disulfide analysis by permitting accurate mass MS and MS/MS information to be collected simultaneously, providing the high-resolution data necessary for differentiating closely related species and confirming structural assignments. And by using BioPharmaView Software to process the dataset, identifying the location of five disulfide linkages in the Fab region of an mAb was completed in a fast and automated fashion.
See the results in the full article by downloading the Biologics Analytical Characterization Compendium >
For more than 20 years, the CDCO has supported academic, commercial, and not‑for‑profit drug discovery programs with deep expertise in pharmaceutical lead optimization. Within the bioanalytical group, their role is to enable rapid and reliable decision‑making through quantitative analysis of candidate drugs in biological matrices.
PFAS are increasingly at the center of regulatory change, scientific research, and industry discussion worldwide. As analytical capabilities improve and expectations around environmental responsibility continue to evolve, understanding the role PFAS play, and how they are being addressed, has never been more important. This blog provides an overview of what PFAS are, why they matter, and how responses from regulators and industry are changing.
Pesticides are widely used in agriculture to protect crops and maintain yield, but their presence in food must be carefully monitored. To safeguard consumers, regulatory authorities worldwide set maximum residue limits (MRLs), often at very low concentrations and across a wide range of compound classes.
Posted by
You must be logged in to post a comment.
Share this post with your network